Progress on human papillomavirus (HPV) infection and cervical cancer prevention in sub-Saharan Africa: Highlights of the 27th International Papillomavirus Conference in Berlin, 17-22 September 2011

Journal of Epidemiology and Global Health

Volumn 2, Issue 2, 2012, Pages 99-102

  El Khatib, Ziad ^a   Tota, Joseph E ^a   Kaufmann, Andreas M ^b  

^a MCGILL UNIVERSITY   (Canada)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cervical cancer; HIV; HPV; Infectious diseases; Sub Saharan Africa

Indexed keywords

AFRICA; CANCER CONTROL; CANCER IMMUNIZATION; CANCER INVASION; CANCER MORTALITY; CANCER PREVENTION; CANCER REGISTRY; CANCER SCREENING; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DRUG COST; EPIDEMIC; GERMANY; HUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; TREATMENT PLANNING; TREND STUDY; UTERINE CERVIX CANCER;

EID: 84864824650     PISSN: 22106006     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jegh.2012.04.001     Document Type: Conference Paper

References (22)

1. Anorlu R.I. Cervical cancer: the sub-Saharan African perspective. Reprod Health Matters 2008, 16(32):41-49.
2. Anorlu R.I., Obodo K., Makwe C.C. Cancer mortality among patients admitted to gynecological wards at Lagos University Teaching Hospital, Nigeria. Int J Gynaecol Obstet 2010, 110(3):268-269.
3. Arbyn M., Castellsague X., de Sanjose S., Bruni L., Saraiya M., Bray F., et al. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2008, 6.
4. Hariri S. HPV vaccine Introduction and Monitoring in Rwanda. In: 27th International Papillomavirus Conference and Clinical Workshop, Berlin; 2011.
5. Remes P, Selestine V, Soteli S, Changalucha J, Kapiga S, Wight D, et al. Is HPV vaccination in primary schools acceptable in Tanzanian communities? In: 27th International Papillomavirus Conference and Clinical Workshop, Berlin; 2011. p. 176 (O-09.07).
6. Watson-Jones D, Baisley K, Ponsiano R, Remes P, Changalucha J, Kapiga S, et al. HPV vaccination in Tanzania: comparison of two school-based delivery strategies. In: 27th International Papillomavirus Conference and Clinical Workshop, Berlin; 2011.
7. Delany-Moretlwe S, Venables E, Rees H, Mac Phail C. Introducing the HPV vaccine into South Africa: Acceptability and feasibility. In: 27th International Papillomavirus Conference and Clinical Workshop, Berlin; 2011. p. 183 (P-09.19).
8. Delany-Moretlwe S, Venables E, Rees H, Mac Phail C. HPV vaccination and a South African adolescent package of care. In: 27th International Papillomavirus Conference and Clinical Workshop, Berlin; 2011. p. 183 (P-09.20).
9. Quentin W, Watson-Jones D, Changalucha J, Hutubessy R, Edmunds J, Hayes R, et al. Costs of delivering HPV vaccine to school girls in Tanzania. In: 27th International Papillomavirus Conference and Clinical Workshop, Berlin; 2011. p. 101 (O-05.05).
10. Levin C, Van Minh H, Odaga J, Sarit Rout S, Nguyen D, Menezes L, et al. Program costs to introduce HPV vaccine in four low-resource settings. In: 27th International Papillomavirus Conference and Clinical Workshop, Berlin; 2011. p. 8 (O-01.7).
11. GAVI Alliance. GAVI Alliance - list of eligible countries for support. 2011 [cited; Available from: <>. http://www.gavialliance.org/support/-apply/countries-eligible-for-support.
12. GAVI Alliance. What people say. 2012 [cited 2012 February 7]; Available from: <>. http://www.gavialliance.org/about/mission/what-people-say/.
13. Maranga O, Hampson L, Oliver A, He X, Kitchener H, Gichangi P, et al. HPV genotypes and HIV in cervical smears from Kenyan women. In: 27th International Papillomavirus Conference and Clinical Workshop, Berlin; 2011. p. 142 (O-07.07).
14. Weiderpass E, Mutyaba T, Kleter B, Quint W, van Doorn L. HPV and HIV infection in Ugandan women referred for colposcopy. In: 27th International Papillomavirus Conference and Clinical Workshop, Berlin; 2011. p. 151 (P-07.23).
15. Huchko M, Smith-McCune K, Sawaya G, Lynch C. HPV types and risk for cervical intraepithelial neoplasia in Zimbabwe. In: 27th International Papillomavirus Conference and Clinical Workshop, Berlin; 2011. p. 184 (P-09.21).
16. Wang L, Kuhn L, Denny L, Wright T. Increased pathogenicity of HPV16 and HPV35 in South African women. In: 27th International Papillomavirus Conference and Clinical Workshop, Berlin; 2011. p. 159 (O-08.04).
17. Mbulawa Z, Marais D, Johnson L, Coetzee D, Williamson A. HPV incidence and clearance in South Africa women and men. In: 27th International Papillomavirus Conference and Clinical Workshop, Berlin; 2011. p. 141 (O-07.05).
18. Mbulawa Z., Marais D., Johnson L., Boulle A., Coetzee D., Williamson A. Influence of human immunodeficiency virus and CD4 count on the prevalence of human papillomavirus in heterosexual couples. J Gen Virol 2010, 12:3023-3031.
19. Tracy J, Schluterman N, Terplan M, Lydecker A, Sow S. High risk HPV infection in women from Mali, West Africa. In: 27th International Papillomavirus Conference and Clinical Workshop, Berlin; 2011. p. 181 (P-09.15).
20. Arbyn M., Schneider A., Gissmann L., Kaufmann A.M. Highlights of the 27th International Papillomavirus Conference and Clinical Workshop: part 2: applied clinical science. Future Virol 2012, 7(1):19-24.
21. Arbyn M., Gissmann L., Schneider A., Kaufmann A.M. Highlights of the 27th International Papillomavirus Conference and Clinical Workshop: part 3: epidemiology and public health. Future Virol 2012, 7(2):127-133.
22. Arbyn M., Gissmann L., Schneider A., Kaufmann A.M. Highlights of the 27th International Papillomavirus Conference and Clinical Workshop: part 1. Future Virol 2011, 6(12):1389-1396.